Oratorio: plano general interior [Material gráfico]
Zaragoza. Palacio de la Aljafería. Palacio taifal. Oratorio. Plano general.
Pérez Veintemilla, José Ignacio
core
Oratorio: plano nadir de la bóveda [Material gráfico]
Zaragoza. Palacio de la Aljafería. Palacio taifal. Oratorio. Plano nadir.
Pérez Veintemilla, José Ignacio
core
Oratorio: plano en altura de la portada del oratorio y de las arquerías [Material gráfico]
Zaragoza. Palacio de la Aljafería. Palacio taifal. Oratorio. Plano en altura. A la izquierda, de frente, portada del oratorio.
Pérez Veintemilla, José Ignacio
core
Effectiveness of Ocrelizumab in Primary Progressive Multiple Sclerosis: a Multicenter, Retrospective, Real-world Study (OPPORTUNITY). [PDF]
Chisari CG +26 more
europepmc +1 more source
[ES] Definición del término Oratorio (subíndice) 2 en el diccionario Dicter.[EN] Definition of the word Oratorio (subíndice) 2 in the dictionary ...
core
Should Age 65 be a cutoff for Primary Progressive Multiple Sclerosis therapy? Real World Data is Critical. [PDF]
Coyle PK.
europepmc +1 more source
Dialectics of Contrasts in the Oratorio On Love and Hatred by Sofia Gubaidulina
Sofia Gubaidulina is an acknowledged luminary of the contemporary classical music world, a composer who created her own sonic universe. The language of her music is grounded in the interplay of binary oppositions, which serve as the starting point for ...
Nadezhda V. Shirieva
doaj +1 more source
Nicolau Copérnico, Tycho Brahe e os Oratorianos em Portugal
A partir de um pequeno opúsculo impresso em 1807 e usado no ensino (elementar) de matérias cosmográficas nas escolas da Congregação do Oratório, é discutida a receção das propostas cosmológicas de Copérnico e Tycho entre os oratorianos, da segunda ...
Luís Tirapicos
doaj +1 more source
Oratorio de San Felipe Neri en San Miguel de Allende
I.O. Reverso: tipografía: "Oratorio de Sn Miguel".
core
Blood neurofilament light levels predict non-relapsing progression following anti-CD20 therapy in relapsing and primary progressive multiple sclerosis: findings from the ocrelizumab randomised, double-blind phase 3 clinical trials. [PDF]
Bar-Or A +17 more
europepmc +1 more source

